1849 Bio
United States· Est.
Engineering custom microbes to unlock copper from low‑grade ores, boosting recovery rates up to 60% without disrupting existing mining processes.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Engineering custom microbes to unlock copper from low‑grade ores, boosting recovery rates up to 60% without disrupting existing mining processes.
Technology Platform
Custom‑engineered microbes designed via genome editing and directed evolution to bioleach copper from specific low‑grade ores, integrated through high‑throughput screening and existing leaching infrastructure.
Opportunities
Scaling pilot successes into licensed microbial formulations for global mining firms could unlock multi‑hundred‑million‑dollar revenue streams within 3–5 years.
Risk Factors
Technical risk of maintaining microbial efficacy at industrial scale and regulatory hurdles for environmental release could delay commercial adoption.
Competitive Landscape
Few companies focus on custom‑engineered microbes for metal extraction; 1849 Bio differentiates through higher recovery rates and seamless integration with existing leaching processes.